Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60.7M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
-1.46M
-
Total reported value, excl. options
-
$127M
-
Value change
-
-$5.31M
-
Put/Call ratio
-
0.31
-
Number of buys
-
21
-
Number of sells
-
-35
-
Price
-
$4.81
Significant Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q2 2023
76 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q2 2023.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 60.7M outstanding shares and own 43.38% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.77M shares), Deep Track Capital, LP (3.92M shares), Sands Capital Ventures, LLC (3.42M shares), Knollwood Investment Advisory, LLC (1.68M shares), Laurion Capital Management LP (1.21M shares), MILLENNIUM MANAGEMENT LLC (1.15M shares), GREAT POINT PARTNERS LLC (1.05M shares), VANGUARD GROUP INC (735K shares), Ikarian Capital, LLC (655K shares), and BlackRock Inc. (483K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.